Literature DB >> 12882523

The application of 2D gel-based proteomics methods to the study of breast cancer.

Robert C Stein1, Marketa J Zvelebil.   

Abstract

The protein complement of breast cells consists of many thousands of proteins. Recent developments in 2D gel electrophoresis technology have made studies requiring the quantitative analysis of a differential proteome, such as comparison between normal and malignant cells or investigation of drug effects on cells, truly feasible. Computer software plays a central part in the comparisons between multiple gels required for such experiments. In addition, software tools allow patterns of coexpression of proteins to be studied, offering potential insights into protein regulation, interactions, and functions, especially when combined with complementary data on gene expression. In this paper, the technology and limitations of 2D gel-based proteomics are reviewed. Techniques for comparing sets of gels at a global level as well as identifying specific protein features that differentiate gels are discussed. Our own experience of studying the breast cell proteome is used to illustrate the difficulties and achievements of differential proteomics.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12882523     DOI: 10.1023/a:1024034031472

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.673


  27 in total

Review 1.  The current state of two-dimensional electrophoresis with immobilized pH gradients.

Authors:  A Görg; C Obermaier; G Boguth; A Harder; B Scheibe; R Wildgruber; W Weiss
Journal:  Electrophoresis       Date:  2000-04       Impact factor: 3.535

2.  Improved two-dimensional gel electrophoresis representation of serum proteins by using ProtoClear.

Authors:  B A Lollo; S Harvey; J Liao; A C Stevens; R Wagenknecht; R Sayen; J Whaley; F G Sajjadi
Journal:  Electrophoresis       Date:  1999 Apr-May       Impact factor: 3.535

3.  Quantitative comparison and evaluation of two commercially available, two-dimensional electrophoresis image analysis software packages, Z3 and Melanie.

Authors:  Babu Raman; Agnes Cheung; Mark R Marten
Journal:  Electrophoresis       Date:  2002-07       Impact factor: 3.535

4.  Cluster analysis of an extensive human breast cancer cell line protein expression map database.

Authors:  Robert A Harris; Alice Yang; Robert C Stein; Kevan Lucy; Luc Brusten; Athula Herath; Raj Parekh; Michael D Waterfield; Michael J O'Hare; Munro A Neville; Martin J Page; Marketa J Zvelebil
Journal:  Proteomics       Date:  2002-02       Impact factor: 3.984

5.  Specific polypeptide differences in normal versus malignant human breast tissues by two-dimensional electrophoresis.

Authors:  P J Wirth; V Egilsson; V Gudnason; S Ingvarsson; S S Thorgeirsson
Journal:  Breast Cancer Res Treat       Date:  1987-11       Impact factor: 4.872

6.  Analysis of the mouse proteome. (I) Brain proteins: separation by two-dimensional electrophoresis and identification by mass spectrometry and genetic variation.

Authors:  C Gauss; M Kalkum; M Löwe; H Lehrach; J Klose
Journal:  Electrophoresis       Date:  1999-03       Impact factor: 3.535

7.  Analysis of proviral integration in human mammary epithelial cell lines immortalized by retroviral infection with a temperature-sensitive SV40 T-antigen construct.

Authors:  A C Stamps; S C Davies; J Burman; M J O'Hare
Journal:  Int J Cancer       Date:  1994-06-15       Impact factor: 7.396

8.  Proteomics of human breast ductal carcinoma in situ.

Authors:  Julia D Wulfkuhle; Dennis C Sgroi; Henry Krutzsch; Kelley McLean; Kelly McGarvey; Melodie Knowlton; She Chen; Hongjun Shu; Aysegul Sahin; Raffael Kurek; Diethelm Wallwiener; Maria J Merino; Emanuel F Petricoin; Yingming Zhao; Patricia S Steeg
Journal:  Cancer Res       Date:  2002-11-15       Impact factor: 12.701

9.  Keratins as markers that distinguish normal and tumor-derived mammary epithelial cells.

Authors:  D K Trask; V Band; D A Zajchowski; P Yaswen; T Suh; R Sager
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

10.  Relative malignant potential of human breast carcinoma cell lines established from pleural effusions and a brain metastasis.

Authors:  R D Zhang; I J Fidler; J E Price
Journal:  Invasion Metastasis       Date:  1991
View more
  6 in total

1.  Serum proteomic signature of human chagasic patients for the identification of novel potential protein biomarkers of disease.

Authors:  Jian-Jun Wen; M Paola Zago; Sonia Nuñez; Shivali Gupta; Federico Nuñez Burgos; Nisha Jain Garg
Journal:  Mol Cell Proteomics       Date:  2012-04-27       Impact factor: 5.911

Review 2.  Laser capture microdissection and advanced molecular analysis of human breast cancer.

Authors:  Andrew P Fuller; Darryl Palmer-Toy; Mark G Erlander; Dennis C Sgroi
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-07       Impact factor: 2.673

3.  Identification of Differential Protein Expression in Hepatocellular Carcinoma Induced Wistar Albino Rats by 2D Electrophoresis and MALDI-TOF-MS Analysis.

Authors:  Vadanasundari Vedarethinam; Karthik Dhanaraj; Ilavenil Soundherrajan; Ravikumar Sivanesan
Journal:  Indian J Clin Biochem       Date:  2015-05-26

4.  Differences in expression of retinal proteins between diabetic and normal rats.

Authors:  Shang-Qing Liu; Jian Kang; Cheng-Jun Li; En-Jie Tang; Bin Wen; Rong Cai; Hui-Jun Yang
Journal:  World J Gastroenterol       Date:  2007-04-14       Impact factor: 5.742

5.  The value of serum biomarkers (Bc1, Bc2, Bc3) in the diagnosis of early breast cancer.

Authors:  Kemal Atahan; Hakan Küpeli; Serhat Gür; Türkan Yiğitbaşı; Yasemin Baskın; Seyran Yiğit; Mehmet Deniz; Atilla Cökmez; Ercüment Tarcan
Journal:  Int J Med Sci       Date:  2011-02-12       Impact factor: 3.738

6.  The case for well-conducted experiments to validate statistical protocols for 2D gels: different pre-processing = different lists of significant proteins.

Authors:  Sreelatha Meleth; Jessy Deshane; Helen Kim
Journal:  BMC Biotechnol       Date:  2005-02-11       Impact factor: 2.563

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.